Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 11/2004

01-06-2004 | Correspondence

The Management of Hypertension in the Overweight and Obese Patient

Is Weight Reduction Sufficient?

Author: Stephan Jacob

Published in: Drugs | Issue 11/2004

Login to get access

Excerpt

Douketis and Sharma[1] recently reviewed the use of dietary and lifestyle modification, anti-obesity or antihypertensive drug therapy in managing hypertension in overweight and obese patients. …
Literature
1.
Douketis JD, Sharma AM. The management of hypertension in the overweight and obese patient: is weight reduction sufficient? Drugs 2004; 64(8): 795–803PubMedCrossRef
2.
Hollander P, Elbein SC, Hirsch IB, et al. Role of orlistat in the treatment of obese patients with type 2 diabetes: a 1-year randomized double-blind study. Diabetes Care 1998; 21: 1288–94PubMedCrossRef
3.
Kelley DE, Bray GA, Pi-Sunyer FX, et al. Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: a 1-year randomized controlled trial. Diabetes Care 2003; 25: 1033–41CrossRef
4.
Miles JM, Leiter L, Hollander P, et al. Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin. Diabetes Care 2002; 25: 1123–8PubMedCrossRef
5.
Toplak H, Sharma AM, Van Gaal L. Orlistat plus diet for 12 months produces rapid and sustained weight loss in overweight or obese non-diabetic patients [abstract]. Int J Obes Relat Metab Disord 2002; 26 Suppl. 1: S152
6.
Sharma AM, Golay A. Effect of orlistat-induced weight loss on blood pressure and heart rate in obese patients with hypertension. J Hypertens 2002; 20: 1873–8PubMedCrossRef
7.
Torgerson JS, Hauptman J, Boldrin MN, et al. XENical in the prevention of Diabetes in Obese Subjects (XENDOS) study. Diabetes Care 2004; 27: 155–61PubMedCrossRef
Metadata
Title
The Management of Hypertension in the Overweight and Obese Patient
Is Weight Reduction Sufficient?
Author
Stephan Jacob
Publication date
01-06-2004
Publisher
Springer International Publishing
Published in
Drugs / Issue 11/2004
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200464110-00007

Other articles of this Issue 11/2004

Drugs 11/2004 Go to the issue

Leading Article

Evolving Strategies for Insulin Delivery and Therapy

Adis Review

Zoledronic Acid

Review Article

Medical Lipid-Regulating Therapy

Therapy in Practice

Mucosal and Systemic Fungal Infections in Patients with AIDS

Adis Drug Evaluation

Valdecoxib

Adis Drug Evaluation

Letrozole